X
19
Padagis, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Setting a smart pace for the extended Topicals Rx marketplace.
One of their notable products is BRIMONIDINE TARTRATE, with a corresponding application number 209158.
Regulatory Information RX
With a dosage strength EQ 0.33% BASE
Dosage Form Route GEL; TOPICAL
Reference Listed Drug No
Approved since 2021-09-23
Therapeutic Equivalence (TE) Code AB